Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor

por Galamb, O, Spisák, S, Sipos, F, Tóth, K, Solymosi, N, Wichmann, B, Krenács, T, Valcz, G, Tulassay, Z, Molnár, B
Publicado 2010

Randomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrence

por Kruis, W., Kardalinos, V., Eisenbach, T., Lukas, M., Vich, T., Bunganic, I., Pokrotnieks, J., Derova, J., Kondrackiene, J., Safadi, R., Tuculanu, D., Tulassay, Z., Banai, J., Curtin, A., Dorofeyev, A. E., Zakko, S. F., Ferreira, N., Björck, S., Diez Alonso, M. M., Mäkelä, J., Talley, N. J., Dilger, K., Greinwald, R., Mohrbacher, R., Spiller, R.
Publicado 2017

Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long‐term extension data from a Phase 3 study

por Schmidt, C., Ahmad, T., Tulassay, Z., Baumgart, D. C., Bokemeyer, B., Howaldt, S., Stallmach, A., Büning, C., Baumgart, Daniel C., Bokemeyer, Bernd, Büning, Carsten, Helwig, Ulf, Howaldt, Stefanie, Hüppe, Dietrich, Krummenerl, Annette, Krummenerl, Thomas, Kühbacher, Tanja, Landry, Wilfried, Lügering, Andreas, Maaser, Christian, Mroß, Michael, Seidler, Ursula, Stallmach, Andreas, Stein, Jürgen, Teich, Niels, Horvath, Gabor, Kristóf, Tünde, László, András, Molnár, Tamás, Salamon, Ágnes, Tulassay, Zsolt, Vincze, Áron, Krayenbuehl, Pierre, Ahmad, Tariq, Beales, Ian, Brookes, Matthew, Campbell, Simon, Cummings, Fraser, Ede, Ronald, Elphick, David, Ireland, Alan, Kejariwal, Deepak, Li, Andy, Mansfield, John
Publicado 2016